Assessing the safety and performance of SYMBOL medical devices in hip surgeries

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the safety and effectiveness of the SYMBOL range of medical devices used in total hip arthroplasty over a period of 10 years. It will involve patients who are undergoing either primary or revision hip surgeries with at least one SYMBOL device. The study will track patient outcomes and device performance to ensure long-term safety and efficacy. Participants must be informed and willing to take part, and they need to be able to understand French.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient age \> 18 years at implantation.
* Patient who will undergo, during the study's period of inclusion, a total hip arthroplasty (primary or revision) with at least one SYMBOL medical device (DEDIENNE Santé).
* Patient informed of his/her participation and willing to participate in the study.
* Patient able to read, write and understand French.

Exclusion Criteria:

* Patient deprived of freedom, under guardianship/curatorship or placed under judicial protection
* Patient unable to follow study procedures.
* Patient who has already been included in the study for a total hip arthroplasty (primary or revision) with at least one SYMBOL medical device.

Where it's running

• Hôpital Privé de la Châtaigneraie
  Beaumont, France Recruiting
• Hôpital Privé du Grand Narbonne
  Montredon-des-Corbières, France Recruiting
• Polyclinique Grand Sud
  Nîmes, France Recruiting
• Clinique Mutualiste Catalane
  Perpignan, France Recruiting
• CH de Péronne
  Péronne, France Recruiting
• Clinique Mutualiste
  Saint-Etienne, France Recruiting

Study contacts

• Principal investigator: Thomas Rousseau — Clinique Mutualiste Catalane
• Study coordinator: Marion Burland
• Email: reg.aff@dedienne-sante.com
• Phone: +33 (0)4 66 28 06 85

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Collarless Actis hip stem for cementless hip replacement in Asian patients

  This study tests how well a collarless Actis hip stem works in adults undergoing primary hip replacement, focusing on outcomes over five years in an East Asian population.

  Recruiting Seoul National University Bundang Hospital · Seongnam-si, Gyeonggi-do · NCT07828080

• Bone marrow injection at the femoral neck fracture site in young adults with intracapsular hip fractures

  This study tests whether injecting the patient’s own bone marrow into a femoral neck fracture helps it heal faster and reduces avascular necrosis in adults aged 18–55 with certain fracture types.

  Recruiting Idlib University · Idlib · NCT07808294

• Tipmed™ Primary Hip Prosthesis: 24-Month Post-Market Follow-Up in Adults

  This PMCF study tests the safety and 24‑month performance of the Tipmed hip prosthesis in adults undergoing primary hip replacement.

  Recruiting at 4 sites TIPMED Medical Device Manufacturing Ltd. Co. · Balıkesir and 3 other locations · NCT07651735

• Hip arthroplasty with a short cementless stem using a direct anterior approach

  This study tests whether a short, cementless hip stem implanted through a minimally invasive direct anterior approach works well in adults with hip arthritis.

  Recruiting Istituto Ortopedico Rizzoli · Bologna · NCT07600632

• Sacral ESPB versus PENG nerve block for pain after hip hemiarthroplasty

  We will see if a sacral erector spinae plane (S-ESPB) block or a pericapsular nerve group (PENG) block gives better pain relief for adults 50–90 having hip hemiarthroplasty for a femoral neck fracture.

  Recruiting Fayoum University Hospital · El Fayoum Qesm, Faiyum Governorate · NCT07442721

• How ciprofol behaves and affects older adults having limb surgery under general anesthesia

  This study tests whether ciprofol provides safe and effective anesthesia for older adults having elective limb surgery by measuring drug levels and clinical responses.

  Recruiting Shanghai Geriatric Medical Center · Shanghai · NCT07301242

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.